![ISPOR Europe 2024 – May 5-8. Register now.]({"type":"image" , "src" : "/sda/112342/JournalAd-ISPOR-2024-Leaderboard.jpg"})
Citations (48)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Tracy J Sims, Kristina S Boye, Susan Robinson & Tessa Kennedy-Martin. (2022) Treatment-Related Attributes of Diabetes Therapies and How People with Type 2 Diabetes Report Their Impact on Indicators of Medication-Taking Behaviors. Patient Preference and Adherence 16, pages 1919-1939.
Read now
Read now
Wisit Kaewput, Charat Thongprayoon, Ram Rangsin, Tarun Bathini, Aldo Torres-Ortiz, Michael A. Mao & Wisit Cheungpasitporn. (2020) Incidence and Risk Factors Associated with Outpatient Hypoglycemia in Patients with Type 2 Diabetes and Chronic Kidney Disease: A Nationwide Study. Endocrine Research 45:4, pages 217-225.
Read now
Read now
Jieruo Liu, Rosa Wang, Michael L. Ganz, Yurek Paprocki, Doron Schneider & James Weatherall. (2018) The burden of severe hypoglycemia in type 2 diabetes. Current Medical Research and Opinion 34:1, pages 179-186.
Read now
Read now
Nicki Hoskins, Christian Klyver Tikkanen & Ulrik Pedersen-Bjergaard. (2017) The economic impact of insulin-related hypoglycemia in Denmark: an analysis using the Local Impact of Hypoglycemia Tool. Journal of Medical Economics 20:4, pages 363-370.
Read now
Read now
Meryl Brod, Michael Wolden, Danielle Groleau & Donald M. Bushnell. (2014) Understanding the economic, daily functioning, and diabetes management burden of non-severe nocturnal hypoglycemic events in Canada: differences between type 1 and type 2. Journal of Medical Economics 17:1, pages 11-20.
Read now
Read now
Articles from other publishers (43)
Lucas A. Myers, Kristi M. Swanson, Amy E. Glasgow & Rozalina G. McCoy. (2022) Management and Outcomes of Severe Hypoglycemia Treated by Emergency Medical Services in the U.S. Upper Midwest. Diabetes Care 45:8, pages 1788-1798.
Crossref
Crossref
Veronique Lambert-Obry, Jean-Philippe Lafrance, Michelle Savoie & Jean Lachaine. (2022) The Impact of Hypoglycemia on Productivity Loss and Utility in Patients With Type 2 Diabetes Treated With Insulin in Real-world Canadian Practice: Protocol for a Prospective Study. JMIR Research Protocols 11:3, pages e35461.
Crossref
Crossref
Natalie H. Au, Alexandria Ratzki-Leewing, Guangyong Zou, Bridget L. Ryan, Susan Webster-Bogaert, Sonja M. Reichert, Judith B. Brown & Stewart B. Harris. (2022) Real-World Incidence and Risk Factors for Daytime and Nocturnal Non-Severe Hypoglycemia in Adults With Type 2 Diabetes Mellitus on Insulin and/or Secretagogues (InHypo-DM Study, Canada). Canadian Journal of Diabetes 46:2, pages 196-203.e2.
Crossref
Crossref
Uffe Søholm, Melanie Broadley, Natalie Zaremba, Patrick Divilly, Giesje Nefs, Zeinab Mahmoudi, Bastiaan de Galan, Ulrik Pedersen-Bjergaard, Alan Brennan, Daniel John Pollard, Rory J McCrimmon, Stephanie A. Amiel, Christel Hendrieckx, Jane Speight, Pratik Choudhary & Frans Pouwer. (2022) Investigating the day-to-day impact of hypoglycaemia in adults with type 1 or type 2 diabetes: design and validation protocol of the Hypo-METRICS application. BMJ Open 12:2, pages e051651.
Crossref
Crossref
René Rodríguez-Gutiérrez, Alejandro Salcido-Montenegro, José Gerardo González-González & Rozalina G McCoy. (2021) Variation in hypoglycemia ascertainment and report in type 2 diabetes observational studies: a meta-epidemiological study. BMJ Open Diabetes Research & Care 9:1, pages e001906.
Crossref
Crossref
Patricia Gómez, Sandra Feijóo, Teresa Braña, Jesús Varela & Antonio Rial. (2019) Minors and Online Gambling: Prevalence and Related Variables. Journal of Gambling Studies 36:3, pages 735-745.
Crossref
Crossref
Tatsuhiko Urakami, Kei Yoshida, Remi Kuwabara, Yusuke Mine, Masako Aoki, Junichi Suzuki & Ichiro Morioka. (2020) Individualization of recommendations from the international consensus on continuous glucose monitoring-derived metrics in Japanese children and adolescents with type 1 diabetes. Endocrine Journal 67:10, pages 1055-1062.
Crossref
Crossref
Gian Paolo Fadini, Michael Feher, Troels Krarup Hansen, Harold W de Valk, Mette Marie Koefoed, Michael Wolden, Esther Zimmermann & Johan Jendle. (2019) Switching to Degludec From Other Basal Insulins Is Associated With Reduced Hypoglycemia Rates: A Prospective Study. The Journal of Clinical Endocrinology & Metabolism 104:12, pages 5977-5990.
Crossref
Crossref
Monika Russel-Szymczyk, Vasil Valov, Alexandra Savova & Manoela Manova. (2019) Cost-effectiveness of insulin degludec versus insulin glargine U100 in adults with type 1 and type 2 diabetes mellitus in Bulgaria. BMC Endocrine Disorders 19:1.
Crossref
Crossref
C. Hendrieckx, N. Ivory, H. Singh, B. M. Frier & J. Speight. (2019) Impact of severe hypoglycaemia on psychological outcomes in adults with Type 2 diabetes: a systematic review. Diabetic Medicine 36:9, pages 1082-1091.
Crossref
Crossref
Virginia ValentineBrett NewswangerSteve PrestrelskiAnthony D. AndreMark Garibaldi. (2019) Human Factors Usability and Validation Studies of a Glucagon Autoinjector in a Simulated Severe Hypoglycemia Rescue Situation. Diabetes Technology & Therapeutics 21:9, pages 522-530.
Crossref
Crossref
Tadej Battelino, Thomas Danne, Richard M. Bergenstal, Stephanie A. Amiel, Roy Beck, Torben Biester, Emanuele Bosi, Bruce A. Buckingham, William T. Cefalu, Kelly L. Close, Claudio Cobelli, Eyal Dassau, J. Hans DeVries, Kim C. Donaghue, Klemen Dovc, Francis J. DoyleIIIIII, Satish Garg, George Grunberger, Simon Heller, Lutz Heinemann, Irl B. Hirsch, Roman Hovorka, Weiping Jia, Olga Kordonouri, Boris Kovatchev, Aaron Kowalski, Lori Laffel, Brian Levine, Alexander Mayorov, Chantal Mathieu, Helen R. Murphy, Revital Nimri, Kirsten Nørgaard, Christopher G. Parkin, Eric Renard, David Rodbard, Banshi Saboo, Desmond Schatz, Keaton Stoner, Tatsuiko Urakami, Stuart A. Weinzimer & Moshe Phillip. (2019) Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range. Diabetes Care 42:8, pages 1593-1603.
Crossref
Crossref
Mary L. JohnsonThomas W. MartensAmy B. CriegoAnders L. CarlsonGregg D. SimonsonRichard M. Bergenstal. (2019) Utilizing the Ambulatory Glucose Profile to Standardize and Implement Continuous Glucose Monitoring in Clinical Practice. Diabetes Technology & Therapeutics 21:S2, pages S2-17-S2-25.
Crossref
Crossref
Ulrik Pedersen‐Bjergaard, Saud Alsifri, Ronnie Aronson, Maja Cigrovski Berković, Gagik Galstyan, Helge Gydesen, Jesper Barner Lekdorf, Bernhard Ludvik, Erik Moberg, Ambady Ramachandran & Kamlesh Khunti. (2019) Comparison of the HAT study, the largest global hypoglycaemia study to date, with similar large real‐world studies. Diabetes, Obesity and Metabolism 21:4, pages 844-853.
Crossref
Crossref
Salem A. Beshyah, Mohamed Hassanein, M. Yakoob Ahmedani, Shehla Shaikh, Ebtesam M. Ba-Essa, Magdy H. Megallaa, Bachar Afandi, Fawzi Ibrahim & Talal Al-Muzaffar. (2019) Diabetic hypoglycaemia during Ramadan fasting: A trans-national observational real-world study. Diabetes Research and Clinical Practice 150, pages 315-321.
Crossref
Crossref
Akiko Nishimura, Shin-ichi Harashima, Kiminori Hosoda, Hidenori Arai & Nobuya Inagaki. (2019) Sex-related differences in frailty factors in older persons with type 2 diabetes: a cross-sectional study. Therapeutic Advances in Endocrinology and Metabolism 10, pages 204201881983330.
Crossref
Crossref
Kathy Ellis, Henrietta Mulnier & Angus Forbes. (2018) Perceptions of insulin use in type 2 diabetes in primary care: a thematic synthesis. BMC Family Practice 19:1.
Crossref
Crossref
Yuexin Tang, Jinan Liu, Hakima Hannachi, Samuel S. Engel, Michael L. Ganz & Swapnil Rajpathak. (2018) Retrospective Cohort Analysis of the Reduced Burden of Hypoglycemia Associated with Dipeptidyl Peptidase-4 Inhibitor Use in Patients with Type 2 Diabetes Mellitus. Diabetes Therapy 9:6, pages 2259-2270.
Crossref
Crossref
Richard Silbert, Alejandro Salcido-Montenegro, Rene Rodriguez-Gutierrez, Abdulrahman Katabi & Rozalina G. McCoy. (2018) Hypoglycemia Among Patients with Type 2 Diabetes: Epidemiology, Risk Factors, and Prevention Strategies. Current Diabetes Reports 18:8.
Crossref
Crossref
Ronnie Aronson, Gagik Galstyan, Margalit Goldfracht, Saud Al Sifri, Lisa Elliott & Kamlesh Khunti. (2018) Direct and indirect health economic impact of hypoglycaemia in a global population of patients with insulin-treated diabetes. Diabetes Research and Clinical Practice 138, pages 35-43.
Crossref
Crossref
Ronnie Aronson, Ronald Goldenberg, Damir Boras, Rasmus Skovgaard & Harpreet Bajaj. (2018) The Canadian Hypoglycemia Assessment Tool Program: Insights Into Rates and Implications of Hypoglycemia From an Observational Study. Canadian Journal of Diabetes 42:1, pages 11-17.
Crossref
Crossref
Peter Adolfsson, Donald Rentoul, Brigitte Klinkenbijl & Christopher G Parkin. (2018) Hypoglycaemia Remains the Key Obstacle to Optimal Glycaemic Control – Continuous Glucose Monitoring is the Solution. European Endocrinology 14:2, pages 50.
Crossref
Crossref
Rifat Emral, Faruque Pathan, Carlos Augusto Yepes Cortés, M. Hesham El-Hefnawy, Su-Yen Goh, Ana Maria Gómez, Angela Murphy, Salah Abusnana, Achmad Rudijanto, Anand Jain, Zhulin Ma & Roberto Mirasol. (2017) Self-reported hypoglycemia in insulin-treated patients with diabetes: Results from an international survey on 7289 patients from nine countries. Diabetes Research and Clinical Practice 134, pages 17-28.
Crossref
Crossref
Kamlesh Khunti, Saud Alsifri, Ronnie Aronson, Maja Cigrovski Berković, Catherine Enters-Weijnen, Tom Forsén, Gagik Galstyan, Petronella Geelhoed-Duijvestijn, Margalit Goldfracht, Helge Gydesen, Rahul Kapur, Nebojsa Lalic, Bernhard Ludvik, Erik Moberg, Ulrik Pedersen-Bjergaard & Ambady Ramachandran. (2017) Impact of hypoglycaemia on patient-reported outcomes from a global, 24-country study of 27,585 people with type 1 and insulin-treated type 2 diabetes. Diabetes Research and Clinical Practice 130, pages 121-129.
Crossref
Crossref
Hanne Haahr, Edmond G. Fita & Tim Heise. (2016) A Review of Insulin Degludec/Insulin Aspart: Pharmacokinetic and Pharmacodynamic Properties and Their Implications in Clinical Use. Clinical Pharmacokinetics 56:4, pages 339-354.
Crossref
Crossref
Akiko Nishimura, Shin-ichi Harashima, Haruna Fukushige, Yu Wang, Yanyan Liu, Kiminori Hosoda & Nobuya Inagaki. (2017) A Large Difference in Dose Timing of Basal Insulin Introduces Risk of Hypoglycemia and Overweight: A Cross-Sectional Study. Diabetes Therapy 8:2, pages 385-399.
Crossref
Crossref
Aila J. Ahola, Markku Saraheimo, Riitta Freese, Sari Mäkimattila, Carol Forsblom & Per-Henrik Groop. (2016) Fear of hypoglycaemia and self-management in type 1 diabetes. Journal of Clinical & Translational Endocrinology 4, pages 13-18.
Crossref
Crossref
Michael Vallis, K. Kovacs Burns, Debbie Hollahan, Stuart Ross & Jina Hahn. (2016) Diabetes Attitudes, Wishes and Needs Second Study (DAWN2): Understanding Diabetes-Related Psychosocial Outcomes for Canadians with Diabetes. Canadian Journal of Diabetes 40:3, pages 234-241.
Crossref
Crossref
Meryl Brod, Gagik Galstyan, Ambika Gopalakrishnan Unnikrishnan, Ilana Harman-Boehm, Vinay Prusty, Fernando Lavalle, Margaret McGill, Angela Murphy & Felix Puchulu. (2016) Self-Treated Hypoglycemia in Type 2 Diabetes Mellitus: Results from the Second Wave of an International Cross-Sectional Survey. Diabetes Therapy 7:2, pages 279-293.
Crossref
Crossref
Lisa Elliott, Carrie Fidler, Andrea Ditchfield & Trine Stissing. (2016) Hypoglycemia Event Rates: A Comparison Between Real-World Data and Randomized Controlled Trial Populations in Insulin-Treated Diabetes. Diabetes Therapy 7:1, pages 45-60.
Crossref
Crossref
Stephen Atkin, Zeeshan Javed & Gregory Fulcher. (2015) Insulin degludec and insulin aspart: novel insulins for the management of diabetes mellitus. Therapeutic Advances in Chronic Disease 6:6, pages 375-388.
Crossref
Crossref
W. A. Parekh, D. Ashley, B. Chubb, H. Gillies & M. Evans. (2015) Approach to assessing the economic impact of insulin‐related hypoglycaemia using the novel Local Impact of Hypoglycaemia Tool. Diabetic Medicine 32:9, pages 1156-1166.
Crossref
Crossref
Francisco J. Ampudia-Blasco, Manuel Galán & Meryl Brod. (2014) A cross-sectional survey among patients and prescribers on insulin dosing irregularities and impact of mild (self-treated) hypoglycemia episodes in Spanish patients with type 2 diabetes as compared to other European patients. Endocrinología y Nutrición 61:8, pages 426-433.
Crossref
Crossref
Francisco J. Ampudia-Blasco, Manuel Galán & Meryl Brod. (2014) A cross-sectional survey among patients and prescribers on insulin dosing irregularities and impact of mild (self-treated) hypoglycemia episodes in Spanish patients with type 2 diabetes as compared to other European patients. Endocrinología y Nutrición (English Edition) 61:8, pages 426-433.
Crossref
Crossref
Jörg Lüdemann, Karsten Milek, Birgit Wilhelm, Alexander Segner & Elmar Jaeckel. (2014) Tageszeitlich flexible Gabe von Insulin degludec bei Patienten mit Typ-1-Diabetes oder Typ-2-DiabetesDaytime flexible application of Insulin degludec in patients with type 1 diabetes or type 2 diabetes. MMW - Fortschritte der Medizin 156:S5, pages 89-97.
Crossref
Crossref
Gagik Radikovich Galstyan. (2014) National advisory board on diabetes mellitus: unsolved issues and new opportunities for diabetes treatment. Diabetes mellitus 17:3, pages 129-133.
Crossref
Crossref
N. Munro & A. H. Barnett. (2014) Incidence, worry and discussion about dosing irregularities and self-treated hypoglycaemia amongst HCPs and patients with type 2 diabetes: results from the UK cohort of the Global Attitudes of Patient and Physicians (GAPP2) survey. International Journal of Clinical Practice 68:6, pages 692-699.
Crossref
Crossref
N. Geelhoed-Duijvestijn, C.G. Östenson, J. Lahtela, R. Weitgasser, M. Markert Jensen & S. Timmermans. (2014) De frequentie en impact van niet-ernstige hypoglycemie bij insulinegebruik in Nederland. Nederlands Tijdschrift voor Diabetologie 12:2, pages 58-63.
Crossref
Crossref
Frank J. Snoek, Tibor R.S. Hajos & Stefanie M.P.A. Rondags. 2014. Hypoglycaemia in Clinical Diabetes. Hypoglycaemia in Clinical Diabetes
323
333
.
Nicola N. Zammitt & Brian M. Frier. 2014. Hypoglycaemia in Clinical Diabetes. Hypoglycaemia in Clinical Diabetes
230
262
.
Meryl Brod, Michael Wolden, Torsten Christensen & Donald M. Bushnell. (2013) Understanding the Economic Burden of Nonsevere Nocturnal Hypoglycemic Events: Impact on Work Productivity, Disease Management, and Resource Utilization. Value in Health 16:8, pages 1140-1149.
Crossref
Crossref
Simona Cammarota, Lucio Marcello Falconio, Dario Bruzzese, Alberico Luigi Catapano, Manuela Casula, Anna Citarella, Luigi De Luca, Maria Elena Flacco, Lamberto Manzoli, Maria Masulli, Enrica Menditto, Andrea Mezzetti, Salvatore Riegler, Ettore Novellino & Gabriele Riccardi. (2013) Lower Rate of Cardiovascular Complications in Patients on Bolus Insulin Analogues: A Retrospective Population-Based Cohort Study. PLoS ONE 8:11, pages e79762.
Crossref
Crossref
Baptist Gallwitz & Thomas Haak. (2013) Insulin degludec — ein neues Basalinsulin zur Behandlung von Typ-1- und Typ-2-DiabetesInsulin degludec — a new basal insulin for the treatment of type 1 and type 2 diabetes. MMW - Fortschritte der Medizin 155:S5, pages 76-82.
Crossref
Crossref